Vascular myocytes are central to brain aging. Small vessel disease (SVD; arteriolosclerosis) is a widespread cause of lacunar stroke and vascular dementia, and is characterised by fibrosis and depletion of vascular myocytes in small penetrating arteries. Vascular endothelial growth factor (VEGF) is associated with brain aging, and VEGFR2 is a potent determinant of cell fate. Here, we tested whether VEGFR2 in vascular myocytes is associated with older age and SVD in human brain.VEGFR2 immunolabelling in deep grey matter was assessed in older people with or without moderate-severe SVD, or in younger people without brain pathology or with a monogenic form of SVD (CADASIL). All cases were without Alzheimer's disease pathology. Myocyte VEGFR2 was associated with increasing age (p=0.0026) but not with SVD pathology or with sclerotic index or blood vessel density. We conclude that VEGFR2 is consistently expressed in small artery myocytes of older people, and may mediate effects of VEGF on brain vascular aging.[word count: 156; <170]
Introduction: Nearly 75% of strokes occur in people over 65 often having co-morbidities such as hypertension and metabolic disarrangement. Despite this, most animal models use young and healthy rodents with poor resultant predictive validity. This study examines the feasibility of modelling stroke in aged, obese rats to better reflect the clinical situation. Method: 12 month old Wistar-Han rats (500-650g, n = 15) were fed a high fat diet containing 60% fat for 8 months. Serial blood samples were taken to assess the development of metabolic syndrome. Some animals were used to determine the optimal occlusion duration of the middle cerebral artery to model ischaemic stroke. Remaining rats underwent this optimised procedure alongside 6-month old controls (n = 10). Survival, weight and functional outcome were monitored post-stroke. Blood vessels collected at termination were assessed for fatty deposits. Results: In the 8 months prior to surgery rats gained a large amount of weight (750-1050g). Obese animals did not become significantly hypertensive (p = 0.79). Blood analysis showed increased C-peptide (p = 0.005), leptin (p = 0.006) and an altered inflammatory response (Eotaxin, IL-4 and RANTES). 30 minutes was determined to be the optimal occlusion length in this model. Survival and functional deficits did not significantly differ from control animals. Full analysis of infarct volumes and vessel histology is ongoing. Discussion: While modifications were required to provide the optimal care for these rats (including restraint, housing density and during surgery heating), this more translational, aged obese model may give a better prediction of therapeutic outcome in stroke research.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.